Key statistics
On Tuesday, Kazia Therapeutics Ltd (KZIA:NAQ) closed at 0.426, 128.30% above the 52 week low of 0.1866 set on Mar 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.4099 |
---|---|
High | 0.428 |
Low | 0.4042 |
Bid | 0.40 |
Offer | 0.42 |
Previous close | 0.4154 |
Average volume | 713.45k |
---|---|
Shares outstanding | 14.90m |
Free float | 2.49m |
P/E (TTM) | -- |
Market cap | 12.69m USD |
EPS (TTM) | -0.8373 USD |
Data delayed at least 15 minutes, as of Oct 08 2024 20:59 BST.
More ▼
Press releases
- Kazia Therapeutics Announces Presentation of Promising Phase I Data Evaluating Concurrent Paxalisib and Radiation Therapy in Patients with Solid Tumor Brain Metastases or Leptomeningeal Metastases Harboring PI3K Pathway Mutations at the American Society for Radiation Oncology 66th Annual Meeting
- Kazia Therapeutics Announces Presentation of EVT801 Clinical Data at 15th Biennial Ovarian Cancer Research Symposium
- KAZIA EXECUTES LICENSING AGREEMENT WITH QIMR BERGHOFER